Quirem Medical B. V., a subsidiary of Terumo Corporation, is a leading brand in the field of Therapeutic Interventional Oncology (TIO). They offer a range of fully integrated solutions for treating liver cancer, including radioembolization, chemoembolization, and ablation.

With a mission to improve the quality of life and survival of cancer patients, Quirem aims to be the partner of choice by providing best-in-class solutions in TIO. As a part of the Terumo Therapeutic Interventional Oncology (TIO), Quirem Medical B. V.

Their goal is to become a leader in the high-growth field of Interventional Oncology by expanding their therapeutics portfolio beyond liver cancer treatment. With their entrepreneurial DNA and commitment to innovation, Quirem Medical B. V